Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download New Approaches to Drug Policies PDF full book. Access full book title New Approaches to Drug Policies by Jonathan D. Rosen. Download full books in PDF and EPUB format.
Author: Jonathan D. Rosen Publisher: Springer ISBN: 1137450991 Category : Social Science Languages : en Pages : 255
Book Description
The US-led war on drugs has failed: drugs remain purer, cheaper and more readily available than ever. Extreme levels of violence have also grown as drug traffickers and organized criminals compete for control of territory. This book points towards a number of crucial challenges, policy solutions and alternatives to the current drug strategies.
Author: Jonathan D. Rosen Publisher: Springer ISBN: 1137450991 Category : Social Science Languages : en Pages : 255
Book Description
The US-led war on drugs has failed: drugs remain purer, cheaper and more readily available than ever. Extreme levels of violence have also grown as drug traffickers and organized criminals compete for control of territory. This book points towards a number of crucial challenges, policy solutions and alternatives to the current drug strategies.
Author: Renaud Colson Publisher: Routledge ISBN: 1317426940 Category : Law Languages : en Pages : 333
Book Description
The drug control regime established by the international community has not succeeded in curbing either the demand for, or the offer of, narcotics. But, despite a series of developments in the Americas – including the legalisation of cannabis in Uruguay and in several states in the United States of America – there is still little support in Europe for repealing drug-prohibition laws. Nevertheless, a gradual policy convergence reveals the emergence of a European model favouring public-health strategies over a strictly penal approach to combatting drugs, while growing transnational support for legalisation indicates the persistence of an alternative paradigm for drug policy. This book examines the various influences on drug policies in Europe, as grassroots movements, NGO networks, private foundations and academic research centres increasingly confront the prevailing discourses of drug prohibition. Pursuing an interdisciplinary approach and bringing together legal scholars, social scientists and practitioners, it provides a comprehensive and critical assessment of drug policy reform in Europe.
Author: Mark A.R. Kleiman Publisher: Oxford University Press ISBN: 0199831386 Category : Political Science Languages : en Pages : 256
Book Description
While there have always been norms and customs around the use of drugs, explicit public policies--regulations, taxes, and prohibitions--designed to control drug abuse are a more recent phenomenon. Those policies sometimes have terrible side-effects: most prominently the development of criminal enterprises dealing in forbidden (or untaxed) drugs and the use of the profits of drug-dealing to finance insurgency and terrorism. Neither a drug-free world nor a world of free drugs seems to be on offer, leaving citizens and officials to face the age-old problem: What are we going to do about drugs? In Drugs and Drug Policy, three noted authorities survey the subject with exceptional clarity, in this addition to the acclaimed series, What Everyone Needs to Know®. They begin, by defining "drugs," examining how they work in the brain, discussing the nature of addiction, and exploring the damage they do to users. The book moves on to policy, answering questions about legalization, the role of criminal prohibitions, and the relative legal tolerance for alcohol and tobacco. The authors then dissect the illicit trade, from street dealers to the flow of money to the effect of catching kingpins, and show the precise nature of the relationship between drugs and crime. They examine treatment, both its effectiveness and the role of public policy, and discuss the beneficial effects of some abusable substances. Finally they move outward to look at the role of drugs in our foreign policy, their relationship to terrorism, and the ugly politics that surround the issue. Crisp, clear, and comprehensive, this is a handy and up-to-date overview of one of the most pressing topics in today's world. What Everyone Needs to Know® is a registered trademark of Oxford University Press.
Author: Committee for the Substance Abuse Coverage Study Publisher: National Academies Press ISBN: 9780309043960 Category : Medical Languages : en Pages : 332
Book Description
Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.
Author: National Academies of Sciences, Engineering, and Medicine Publisher: National Academies Press ISBN: 0309498511 Category : Medical Languages : en Pages : 103
Book Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Author: Thomas Babor Publisher: Oxford University Press ISBN: 0192550268 Category : Medical Languages : en Pages : 436
Book Description
Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.
Author: Ulrich Nielsch Publisher: Springer ISBN: 3319289144 Category : Medical Languages : en Pages : 341
Book Description
This volume gives an overview of state of the art technologies and future developments in the field of preclinical pharmaceutical research. A balanced mix of experts from academia and industry give insight in selected new developments in the drug discovery pathway. The topics cover the different parts of the drug discovery process, starting with new developments in the target identification and validation area. The lead generation part as a next step focuses on the requirements and technologies to identify new small molecules as lead compounds for further optimization; in a second section the technologies to identify biologics as leads are addressed. The final part focuses on the pharmacological models and technologies to characterize new compounds and the impact of biomarkers to facilitate the transfer of drug candidates into the development phase.
Author: Institute of Medicine Publisher: National Academies Press ISBN: 0309292492 Category : Medical Languages : en Pages : 118
Book Description
Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline. There are several challenges to the current drug development pipeline for nervous system disorders. The fundamental etiology and pathophysiology of many nervous system disorders are unknown and the brain is inaccessible to study, making it difficult to develop accurate models. Patient heterogeneity is high, disease pathology can occur years to decades before becoming clinically apparent, and diagnostic and treatment biomarkers are lacking. In addition, the lack of validated targets, limitations related to the predictive validity of animal models - the extent to which the model predicts clinical efficacy - and regulatory barriers can also impede translation and drug development for nervous system disorders. Improving and Accelerating Therapeutic Development for Nervous System Disorders identifies avenues for moving directly from cellular models to human trials, minimizing the need for animal models to test efficacy, and discusses the potential benefits and risks of such an approach. This report is a timely discussion of opportunities to improve early drug development with a focus toward preclinical trials.
Author: Thomas F. Babor Publisher: OUP Oxford ISBN: 0199557128 Category : Medical Languages : en Pages : 352
Book Description
Drug use represents a significant burden to public health through disease, disability and social problems, and policy makers are becoming increasingly interested in how to develop evidence-based drug policy. It is therefore crucial to strengthen the links between addiction science and drug policy.Drug Policy and the Public Good is collaboratively written by an international group of career scientists to provide an analytical basis on which to build relevant global drugpolicies, and to inform policy makers who have direct responsibility for public health and social welfare.Drug Policy and the Public Good presents, in a comprehensive, practical, and readily accessible form, the accumulated scientific knowledge on illicit drugs that has direct relevance to the development of drug policy on local, national, and international levels. The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidencein five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal marketthrough prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated.The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions anddecriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated.By locating drug policy primarily within the realm of public health, this book draws attention to the growing tendency of governments, both national and local, to consider illegal psychoactive substances as a major determinant of ill health, and to organize societal responses accordingly. It will appeal to those involved in both addiction science and drug policy, as well as those in the wider fields of public health, health policy, epidemiology, primary prevention, and treatment services.A companion volume published by Oxford University Press, Alcohol: no ordinary commodity - research and public policy, is also available.
Author: Jonathan D. Rosen
Author: Jonathan D. Rosen
Author: Renaud Colson
Author: Mark A.R. Kleiman
Author: Committee for the Substance Abuse Coverage Study
Author: National Academies of Sciences, Engineering, and Medicine
Author: Thomas Babor
Author: Ulrich Nielsch
Author: Institute of Medicine
Author: Timothy Lynch
Author: Thomas F. Babor